These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34840628)

  • 1. The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
    Liu W; Zhang F; Quan B; Li M; Lu S; Li J; Chen R; Yin X
    Dis Markers; 2021; 2021():3514827. PubMed ID: 34840628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pretreatment albumin to globulin ratio, a validated biomarker, predicts prognosis in hepatocellular carcinoma.
    Zhang J; Liu X; Yang Z; Chen Y; Luo R
    J BUON; 2016; 21(4):925-934. PubMed ID: 27685915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
    Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
    Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion.
    Ma M; Xie K; Jin T; Xu F
    BMC Cancer; 2024 May; 24(1):617. PubMed ID: 38773511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram.
    Wang S; Deng Y; Yu X; Zhang XW; Huo CL; Sun ZG; Chang H
    Sci Rep; 2021 Jul; 11(1):13814. PubMed ID: 34226605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy.
    Zhang F; Lu SX; Hu KS; Gan YH; Chen Y; Ge NL; Yang BW; Zhang L; Chen RX; Ren ZG; Yin X
    Int J Hyperthermia; 2021; 38(1):1-10. PubMed ID: 33400889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study.
    Lu N; Sheng S; Xiong Y; Zhao C; Qiao W; Ding X; Chen J; Zhang Y
    Front Immunol; 2024; 15():1459740. PubMed ID: 39315112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
    Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
    Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.
    Lu Z; Sun Z; Liu C; Shi X; Li R; Shao W; Zheng Y; Li Y; Song J
    BMC Cancer; 2021 Jun; 21(1):751. PubMed ID: 34187430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
    Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
    BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    Huang J; Cui W; Xie X; Lin K; Jin D; Xie X; Zhuang B
    Int J Hyperthermia; 2023; 40(1):2256498. PubMed ID: 37733400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
    Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
    J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma.
    Chen J; Fang A; Chen M; Tuoheti Y; Zhou Z; Xu L; Chen J; Pan Y; Wang J; Zhu H; Zhang Y
    Cancer Med; 2018 Oct; 7(10):5027-5035. PubMed ID: 30259688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
    Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH
    Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
    Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
    Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Role of Albumin-Bilirubin Grade in Hepatocellular Carcinoma After Ultrasound-guided Percutaneous Radiofrequency Ablation: A Single-center Experience Over a Decade.
    Long H; Xie X; Huang G; Huang T; Xie X; Liu B
    Surg Laparosc Endosc Percutan Tech; 2022 Jun; 32(3):350-356. PubMed ID: 35297807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.